Biointron’s Q2 2025 antibody industry report aims to explore the events and trends of the biopharmaceutical industry in April, May, and June.
Biointron’s Q1 2025 annual antibody report aims to explore the events and trends of the biopharmaceutical industry in 2025 (January, February, March).
Sjögren’s disease (SjD) is a chronic, systemic autoimmune disorder characterized by lymphocytic infiltration of exocrine glands, most commonly the salivary and lacrimal glands, often accompanied by multi-organ extra-glandular involvement. Despite its substantial morbidity, therapeutic intervention
Time: August 11 - 13, 2025
Location: Philadelphia, Pennsylvania
Booth: #1
Time: September 22 - 25, 2025
Location: Boston, MA
Booth: #410
Time: September 30 - October 2, 2025
Location: Basel, Switzerland
Booth: #713
Biointron’s Lunch & Learn with MassBio was held in Boston, MA, on May 9. The session focused on the advancements in antibody discovery in the biopharma industry and featured three key speakers: Dr. Hitesh Soni (Director of In Vivo Pharmacology at Tectonic Therapeutic Inc.), Dr. Lei Shi. (SVP at
In this webinar, Dr. Brady Wu will discuss bispecific antibody drugs and their production.
The demand for fully human therapeutic antibodies continues to grow, driving the need for more efficient discovery platforms.
Case 1: Tag-Free Vaccine Protein. During the generation of stable cell lines, cells are selected and screened to identify clones that stably express t···
Biointron has developed our own CHOK1-Fut8KO expression platform for afucosylated antibodies.
At Biointron, we deeply value your insights and experiences with our products and services. To show our appreciation, we've launched an exciting Review & Reward Program with Biocompare - this is your opportunity to share your thoughts and be rewarded for your valuable input!
At Biointron, we deeply value your insights and experiences with our products and services. To show our appreciation, we've launched an exciting Review & Reward Program with Biocompare - this is your opportunity to share your thoughts and be rewarded for your valuable input!
Spotlight on Antibodies is a podcast from Biointron, where we bring you the latest antibody industry trends. This July, recent research includes computational tools for nanodiscs, antibody-drug conjugate (ADC) development, and antibody-antigen research.
Spotlight on Antibodies is a podcast from Biointron, where we bring you the latest antibody industry trends. This June, recent research includes VHH antibodies, antibody-drug conjugates in oncology, and antibody engineering as a countermeasure to drug resistance.
Spotlight on Antibodies is a podcast from Biointron, where we bring you the latest antibody industry trends. This May, top news includes BCMA-Targeted Therapies, Multifunctional (Natural Killer Cell Engagers), and Engineering IgE Antibodies.
抗体薬物複合体（Antibody-Drug Conjugates, ADC）は、がん治療において革新的なターゲット型治療薬の一つであり、モノクローナル抗体（mAb）の高い特異性と、低分子抗がん薬の強力な細胞障害作用を組み合わせたものです。この構造により、ADCは化学療法薬をがん細胞に選択的に送達し、正常組織へのダメージを最小限に抑えることを目的としています。
ScientistとScience Exchangeとのご利用可能です。
